Shigella is a group of bacteria that causes shigellosis, a type of food poisoning. The infection can cause belly pain, fever, and watery or bloody diarrhea. You may feel a sharp cramp in your ...

GSK has licensed its shigella vaccine candidate to Bharat Biotech. The Big Pharma, which has vowed to help Bharat with trial design and fundraising, framed the deal as a way to get the vaccine to ...

Shigella spreads very easily, with only a tiny amount of the bacteria required to trigger illness. People are exposed when bacteria present in fecal matter come into contact with the nose or mouth.

A 2024 shigella outbreak killed five Jacksonville Zoo apes. What you should know about the highly contagious illness that can affect humans, too.

GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...

Doctors believe he had Shigella. "When I first heard, I was like, that's crazy. I ate there the 21st, and I have all these symptoms appearing, and it described it down to a T.

Shigella infection causes fever and diarrhea, which may become bloody. These symptoms occur one to two days after coming in contact with the bacteria. Symptoms typically last 5 to 7 days, ...

A shigella outbreak among Jacksonville zoo apes recently killed one of its gorillas. What you should know about the illness, which can affect humans, too.

Shigella bacteria can cause stomach pain, diarrhea and fever. A UW Health doctor told FOX6 News, while it can be difficult to contain, people should not panic. However, they should take precautions.

Shigella infection explained the persistence of symptoms despite treatment for gonorrhoea. The patient was treated with ciprofloxacin (500 mg twice daily). Symptoms resolved within 48 hours.

Shigella sickens 38 people in five countries By Joe Whitworth on February 11, 2025 European public health officials are monitoring an outbreak linked to international travel on long-haul flights.

Shigella causes an estimated 450,000 infections in the U.S. each year, and antimicrobial resistant infections result in an estimated $93 million in direct medical costs.